Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-06 11:37:41 ET NVAX

Published on 05/06/2026 at 11:37 am EDT

Novavax, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 139.51 million compared to USD 666.66 million a year ago. Net loss was USD 9.49 million compared to net income of USD 518.65 million a year ago.

Basic loss per share from continuing operations was USD 0.06 compared to basic earnings per share from continuing operations of USD 3.22 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to diluted earnings per share from continuing operations of USD 2.93 a year ago.